Literature DB >> 2788660

DNA probes for the identification of Haemophilus ducreyi.

L M Parsons1, M Shayegani, A L Waring, L H Bopp.   

Abstract

Haemophilus ducreyi ATCC 33922, a virulent, well-characterized strain, was used to construct a genomic library in a bacteriophage expression vector. Three DNA fragments were selected for use as probes on the basis of their ability to encode H. ducreyi-specific proteins, as demonstrated by reactivity with rabbit polyclonal antiserum. With DNA-DNA hybridization, the three probes, labeled with 32P, reacted strongly with 16 strains of H. ducreyi obtained from a variety of sources. Thirty-seven other bacterial isolates, representing 33 different species and including organisms likely to be encountered in the urogenital tract, were also tested with the three probes. Twenty-eight of these isolates, including the genital pathogen Neisseria gonorrhoeae, showed no hybridization with the probes. In addition, herpes simplex virus-infected tissue culture cells and Treponema pallidum-infected rabbit testicular fluid were also completely nonreactive. Nine isolates, six belonging to other Haemophilus species and three belonging to Pasteurella species, reacted weakly with the probes when approximately 3.0 x 10(7) to 6.0 x 10(7) CFU was tested. When 10(5) to 10(6) CFU of these organisms was tested, the weak reactions could no longer be seen. Yet this number of H. ducreyi still reacted strongly. In fact, the three probes consistently detected 10(4) CFU of H. ducreyi in pure and mixed cultures and even produced a weak signal when only 10(3) CFU was present. It is clear from our results that use of these probes will greatly facilitate the laboratory diagnosis of this genital pathogen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788660      PMCID: PMC267589          DOI: 10.1128/jcm.27.7.1441-1445.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  G W Hammond; C J Lian; J C Wilt; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

2.  Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.

Authors:  Y Dangor; S D Miller; F da L Exposto; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

3.  An indirect fluorescent antibody technique for Haemophilus ducreyi.

Authors:  G A Denys; T A Chapel; C D Jeffries
Journal:  Health Lab Sci       Date:  1978-07

4.  Isolation and identification of Haemophilus ducreyi in a clinical study.

Authors:  F O Sottnek; J W Biddle; S J Kraus; R E Weaver; J A Stewart
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

5.  An outbreak of chancroid in Orange County, California: descriptive epidemiology and disease-control measures.

Authors:  C A Blackmore; K Limpakarnjanarat; J G Rigau-Pérez; W L Albritton; J R Greenwood
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

6.  A taxonomic study of the genus Haemophilus, with the proposal of a new species.

Authors:  M Kilian
Journal:  J Gen Microbiol       Date:  1976-03

7.  Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America.

Authors:  G W Hammond; M Slutchuk; J Scatliff; E Sherman; J C Wilt; A R Ronald
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

8.  Heterospecific transformation in the genus Haemophilus.

Authors:  W L Albritton; J K Setlow; M Thomas; F Sottnek; A G Steigerwalt
Journal:  Mol Gen Genet       Date:  1984

9.  Virulence factors of Haemophilus ducreyi.

Authors:  J A Odumeru; G M Wiseman; A R Ronald
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Escherichia vulneris: a new species of Enterobacteriaceae associated with human wounds.

Authors:  D J Brenner; A C McWhorter; J K Knutson; A G Steigerwalt
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

View more
  13 in total

Review 1.  Diagnostic tests for chancroid.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

2.  The Use of Molecular Techniques for the Diagnosis and Epidemiologic Study of Sexually Transmitted Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

Review 3.  Laboratory techniques in the investigation of chancroid, lymphogranuloma venereum and donovanosis.

Authors:  E Van Dyck; P Piot
Journal:  Genitourin Med       Date:  1992-04

4.  Isolation and characterization of a transposon-induced cytotoxin-deficient mutant of Pseudomonas aeruginosa.

Authors:  L H Bopp; A L Baltch; M C Hammer; M A Franke; R P Smith; F Lutz
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

5.  Direct identification of bacterial isolates in blood cultures by using a DNA probe.

Authors:  T E Davis; D D Fuller
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

6.  Simplified PCR for detection of Haemophilus ducreyi and diagnosis of chancroid.

Authors:  B West; S M Wilson; J Changalucha; S Patel; P Mayaud; R C Ballard; D Mabey
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

7.  The laboratory diagnosis of Haemophilus ducreyi.

Authors:  Michelle Alfa
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-01       Impact factor: 2.471

8.  Molecular analysis of the Haemophilus ducreyi groE heat shock operon.

Authors:  L M Parsons; A L Waring; M Shayegani
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 9.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

10.  Species-specific identification of and distinction between Borrelia burgdorferi genomic groups by using 16S rRNA-directed oligonucleotide probes.

Authors:  R T Marconi; L Lubke; W Hauglum; C F Garon
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.